Comparisons14 min readUpdated 2025-11-25

    Cheapest Wegovy Alternatives 2026: From $99/Month

    Explore the cheapest Wegovy alternatives in 2026. Compare compounded semaglutide options starting at $99/month that deliver the same active ingredient at up to 90% less.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. This guide compares the most affordable Wegovy alternatives available in 2026, with a focus on compounded semaglutide options that deliver the same active ingredient at dramatically lower cost.

    Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.

    Why Patients Are Looking for Wegovy Alternatives

    Wegovy (semaglutide 2.4mg) set the standard for pharmaceutical weight loss when it launched, delivering average weight loss of 15 percent of body weight in clinical trials — a result that no previous weight loss medication had matched. The drug genuinely works, and for millions of patients struggling with obesity, it represents a potentially life-changing treatment option.

    The problem is not Wegovy's effectiveness — it is Wegovy's price. At $1,300 to $1,500 per month without insurance, brand-name Wegovy is financially inaccessible for the vast majority of Americans. Even patients with insurance often face coverage denials, prior authorization delays, and copays that stretch household budgets to the breaking point. The full cost analysis of Wegovy in 2026 reveals just how significant the financial barrier is.

    Additionally, persistent supply shortages have left many patients unable to fill their Wegovy prescriptions even when they can afford the medication. This combination of high cost and unreliable availability has created massive demand for alternatives that deliver the same clinical benefits at accessible price points — and the market has responded.

    The Best Wegovy Alternatives in 2026

    Not all alternatives are created equal. The following options represent the most legitimate, effective, and affordable paths to accessing the weight loss benefits of semaglutide and related medications without paying brand-name Wegovy prices.

    1. Compounded Semaglutide (Best Value)

    Compounded semaglutide is the most direct Wegovy alternative because it contains the exact same active ingredient — semaglutide — prepared by licensed compounding pharmacies. The mechanism of action, clinical effects, and expected outcomes are identical. The difference is the price: compounded semaglutide typically costs $99 to $199 per month compared to Wegovy's $1,300 or more.

    Through Trimi, compounded semaglutide starts at $149 per month with everything included — medication, board-certified provider consultations, ongoing medical oversight, and free shipping. There are no hidden fees, no consultation surcharges, and no long-term contracts. Patients can start treatment quickly through the online assessment process and typically receive their medication within 5 to 7 days.

    2. Compounded Tirzepatide (Strongest Alternative)

    For patients who want the maximum weight loss potential, compounded tirzepatide is worth considering. Tirzepatide — the active ingredient in Mounjaro and Zepbound — is a dual GIP/GLP-1 receptor agonist that produced even greater weight loss than semaglutide in clinical trials, with average results of 20 to 22.5 percent of body weight. Compounded tirzepatide through Trimi starts at approximately $125 per month.

    3. Ozempic (Off-Label, If Insured)

    Ozempic contains semaglutide at a lower maximum dose (2mg vs Wegovy's 2.4mg) and is FDA-approved for type 2 diabetes. Some patients with insurance coverage for Ozempic use it off-label for weight loss. While the maximum dose is lower than Wegovy, many patients achieve significant weight loss on Ozempic. The retail price ($900 to $1,100/month) is still expensive, but insurance coverage for diabetes may make it more accessible for patients with both diabetes and weight management goals.

    4. Wegovy Savings Card + Insurance

    For patients with commercial insurance that covers Wegovy, Novo Nordisk's savings card can reduce copays significantly. This is the only pathway to accessing actual brand-name Wegovy at a reduced cost, but it requires insurance coverage as a prerequisite. Patients without insurance cannot use the savings card. For a detailed comparison, see our Wegovy savings card analysis.

    Cost Comparison: All Wegovy Alternatives

    AlternativeMonthly CostActive IngredientPrescription Required
    Wegovy (Brand)$1,300 - $1,500Semaglutide 2.4mgYes
    Compounded Semaglutide$99 - $199Semaglutide (custom dose)Yes
    Compounded Tirzepatide$125 - $250Tirzepatide (custom dose)Yes
    Ozempic (Off-Label)$900 - $1,100Semaglutide 0.25-2mgYes
    Zepbound (Brand)~$1,060TirzepatideYes

    How to Choose the Right Alternative

    Selecting the right Wegovy alternative depends on your priorities, budget, and medical situation. Here is a framework to help you decide.

    If saving money is the top priority: Compounded semaglutide from Trimi at $99/mo delivers the same active ingredient at 90% less cost

    If maximum weight loss is the goal: Compounded tirzepatide may offer greater results based on clinical trial data

    If you have insurance that covers GLP-1 medications: Check whether Wegovy, Ozempic, or Zepbound are on your formulary

    If you have diabetes and need weight loss: Ozempic or Mounjaro may offer dual benefits with potential insurance coverage

    If speed of access matters: Telehealth compounded options typically deliver faster than navigating insurance authorization

    For most patients — particularly those without strong insurance coverage for brand-name medications — compounded semaglutide through a specialized provider like Trimi represents the optimal combination of effectiveness, affordability, and accessibility. The medication is the same; the financial burden is dramatically different.

    Quality Assurance for Compounded Alternatives

    When choosing a compounded semaglutide provider, quality verification is essential. The active ingredient may be the same, but the quality of compounding can vary between pharmacies. Here is what to look for in a reputable provider.

    Provider partners with PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy

    Third-party potency and sterility testing is conducted on compounded medications

    Licensed healthcare providers conduct thorough medical evaluations before prescribing

    Transparent pricing with no hidden fees or unexplained charges

    Clear information about pharmacy identity and quality certifications

    Responsive customer support and medical team for questions and concerns

    Trimi meets all of these standards, partnering exclusively with accredited compounding pharmacies and providing board-certified medical oversight throughout your treatment journey. For more details on evaluating compounded medication quality, see our quality verification guide.

    Bottom Line

    Wegovy is a remarkable medication, but its price puts it out of reach for most patients. The good news is that the same active ingredient — semaglutide — is available through compounded alternatives at dramatically lower cost. Compounded semaglutide from Trimi starts at $149 per month compared to $1,300 or more for brand-name Wegovy, making effective GLP-1 weight loss treatment accessible to the millions of patients who need it but cannot afford brand-name pricing.

    The medication works regardless of whether it comes from Novo Nordisk or a compounding pharmacy. What matters is choosing a reputable provider, maintaining consistent treatment, and working with a medical team that supports your weight loss journey. Start with Trimi's simple assessment process to see if compounded semaglutide is right for you.

    For the same Wegovy-vs-compounded comparison framed around price and 50-state legality, see our cheap Wegovy alternative 2026 guide ($99/mo). If you want a step-by-step walkthrough of the online intake itself, our how online GLP-1 prescriptions work explainer covers everything from intake form to delivery.

    Frequently Asked Questions

    What is the cheapest alternative to Wegovy in 2026?

    The cheapest legitimate alternative to Wegovy in 2026 is compounded semaglutide, available through telehealth providers starting at approximately $99 to $149 per month. Compounded semaglutide contains the same active ingredient as Wegovy — semaglutide — but is prepared by licensed compounding pharmacies at a fraction of the brand-name cost. Through Trimi, compounded semaglutide starts at $149 per month with all consultations, medical oversight, and shipping included.

    Are Wegovy alternatives as effective as the brand-name drug?

    Compounded semaglutide alternatives contain the same active molecule as Wegovy, so the pharmacological effectiveness is the same. The STEP clinical trials demonstrated 15 to 17 percent average weight loss with semaglutide 2.4mg — results that apply to the molecule regardless of its source. Individual results depend on dosing, adherence, lifestyle factors, and metabolic response. The key is ensuring your compounded semaglutide comes from an accredited pharmacy with proper quality testing.

    Is it safe to use a Wegovy alternative?

    Compounded semaglutide from accredited compounding pharmacies is generally considered safe. The active ingredient is identical to Wegovy, so the safety profile of the molecule is the same. The variable is the quality of compounding — which is why choosing a provider that partners with PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy is critical. Avoid providers that cannot verify their pharmacy accreditation or that offer suspiciously low prices that may indicate quality compromises.

    Can I switch from Wegovy to a compounded alternative?

    Yes, switching from Wegovy to compounded semaglutide is straightforward. Your new provider will prescribe the equivalent dose of compounded semaglutide based on your current Wegovy dose. Since the active ingredient is identical, there is no transition period or dose adjustment needed. Many patients make this switch to save money without any interruption in treatment or change in results. Your provider will ensure continuity of care throughout the transition.

    Do I need a prescription for Wegovy alternatives?

    Yes, all legitimate semaglutide alternatives require a prescription from a licensed healthcare provider. This is true whether the medication is brand-name Wegovy or compounded semaglutide. Any source offering semaglutide without a prescription requirement should be avoided as it is operating outside legal and safety guidelines. Telehealth platforms like Trimi connect you with licensed providers who evaluate your health history and prescribe appropriately.

    Are there non-semaglutide alternatives to Wegovy?

    Yes, tirzepatide — available as brand-name Mounjaro or Zepbound, or as compounded tirzepatide — is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss in clinical trials (20 to 22.5 percent average). Compounded tirzepatide is available through providers like Trimi starting at approximately $125 per month. Other GLP-1 medications and older weight loss drugs exist but generally produce less dramatic results than semaglutide or tirzepatide.

    How quickly can I get a Wegovy alternative?

    Through telehealth providers like Trimi, the process from initial health assessment to medication delivery typically takes 5 to 10 days. This includes the online health assessment (same day), provider review and prescription (usually within 24 to 48 hours), pharmacy compounding and shipping (3 to 7 days). This is often faster than obtaining brand-name Wegovy through traditional channels, where prior authorization alone can take weeks.

    Sources & References

    1. STEP 1 trial: semaglutide 2.4mg for weight management (NEJM, 2021).
    2. SURMOUNT-1 trial: tirzepatide for obesity (NEJM, 2022).
    3. FDA guidance on drug compounding.
    4. Wegovy prescribing information from the FDA.
    5. NABP compounding pharmacy accreditation standards.
    6. NIDDK overview of prescription weight loss medications.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi provides compounded semaglutide as an alternative to brand-name Wegovy — readers should be aware of our perspective when evaluating the information presented.

    What are alternatives to Wegovy in 2026?

    Wegovy alternatives as of May 2026 span several categories. Brand alternatives with different active ingredients: Zepbound (brand tirzepatide, FDA-approved 2023 for chronic weight management) produces ~20-22.5% body-weight reduction at 72 weeks per SURMOUNT-1 — superior weight-loss outcome vs Wegovy's ~14.9% per STEP 1. Brand Mounjaro is the same active ingredient (tirzepatide) approved for type 2 diabetes; sometimes prescribed off-label for weight loss. Compounded semaglutide via licensed telehealth: same active ingredient as Wegovy at dramatically lower cost. Trimi Health $99/month annual ($1,188/year all-inclusive — medication, US-licensed prescribing clinician via Beluga Health 50-state network, dose changes, refills, free shipping) — saves approximately $15,000/year vs cash-pay brand Wegovy retail (~$1,349/mo). Other compounded telehealth providers: Hims $199/mo, Ro $145-$199/mo, Mochi $179/mo, Henry Meds $145/mo — all higher than Trimi annual rate. Compounded tirzepatide alternative: Trimi $125/month annual ($1,500/year all-inclusive) provides tirzepatide at compounded pricing — combines superior efficacy of tirzepatide with cost savings. Investigational alternatives in development: retatrutide (triple-receptor agonist, ~24% loss in phase 2 TRIUMPH-1) is NOT FDA-approved as of May 2026; expected approval 2027-2028. Other earlier-stage molecules (cagrisema, amycretin, survodutide) further from approval. Best-fit selection: tirzepatide for patients seeking higher weight-loss target; compounded semaglutide for lowest cost on Wegovy-equivalent therapy; brand Wegovy with insurance + Manufacturer Savings Card for premium experience if covered. Verify any compounded provider's 503A pharmacy disclosure (VialsRx Texas State Board #35264, GreenwichRx for Trimi), US-licensed prescribing clinician network, LegitScript certification.

    Tirzepatide (Zepbound, compounded): 20-22.5% loss vs Wegovy 14.9%.
    Trimi compounded sema $99/mo annual = ~93% savings vs brand cash-pay.
    Investigational: retatrutide ~24% (not available till 2027-2028).

    Key Takeaways

    • Wegovy alternatives May 2026: brand tirzepatide (Zepbound, ~20-22.5% loss vs sema ~14.9%), brand Mounjaro (off-label weight loss), compounded semaglutide via licensed telehealth.
    • Compounded options dramatically cheaper: Trimi $99/mo annual sema vs Wegovy $1,349/mo retail = ~93% savings.
    • Other compounded providers: Hims $199/mo, Ro $145-$199/mo, Mochi $179/mo, Henry Meds $145/mo — all higher than Trimi annual.
    • Investigational alternatives: retatrutide (~24% phase 2 data; not FDA-approved as of May 2026, expected 2027-2028).
    • Best alternatives selection: tirzepatide for higher weight-loss target; compounded semaglutide for lowest cost; brand Wegovy with insurance + savings card for premium experience.

    Wegovy vs. Trimi Compounded Semaglutide — 2026 Comparison

    Both deliver the same active ingredient (semaglutide). Wegovy is the FDA-approved brand finished product from Novo Nordisk; Trimi dispenses compounded semaglutide via 503A sterile compounding pharmacies at ~93% lower cash-pay cost.

    Wegovy vs. Trimi Compounded Semaglutide — 2026 Comparison
    Wegovy (Novo Nordisk)Trimi Compounded Semaglutide
    Active ingredientSemaglutideSemaglutide
    Cash-pay price~$1,349/month$99/month (annual plan)
    Insurance coverageRequired (often denied for weight loss)Cash-pay — no insurance needed
    FDA approvalFDA-approved finished product (2021)Compounded preparation (active ingredient FDA-approved)
    Dose customizationFixed factory dosesPer-prescription compounded doses
    PharmacyRetail / specialty pharmacyVialsRx (TX #35264), GreenwichRx (503A)
    Clinician accessPrimary care or specialist referralBeluga Health 50-state telehealth
    Average weight loss (active ingredient)14.9% at 68 weeks (STEP 1)Same active ingredient → same trial evidence applies

    Source: STEP 1 Trial (Wilding et al., NEJM 2021) + Trimi pricing 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Asad Niazi, MD, MPH

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038
    3. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    4. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    5. U.S. Food and Drug Administration (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.Read Study
    6. U.S. Food and Drug Administration (2026). BeSafeRx: Your Source for Online Pharmacy Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Complete guide covering legally buying semaglutide online in the USA in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredients at

    Complete guide covering Wegovy supply shortages and semaglutide access in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredients a

    Complete guide covering GLP-1 medications with the fewest GI side effects in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredient

    Complete guide covering affordable telehealth weight loss programs in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredients at up

    Start your GLP-1 journey — from $99/mo

    Get Started